Saint-Vincent Hospital
Lille, Haut-de-France, 59000, France
NCT Number: NCT04503525
The nutritional consequences of the infection by the SARS-CoV-2 are as follows:
* A severe respiratory infection induces an inflammatory syndrome and hypercatabolism, as well as an increase in energy expenditure related to ventilatory work; nutritional requirements (calories and protein) are therefore increased. * Food intake is often reduced by several factors: anorexia secondary to infection, respiratory discomfort, anosmia, ageusia, obesity, stress, confinement, organizational problems limiting meal assistance.
Then, it is important to asses the nutritional status of COVID patients hospitalized in conventional COVID units (excluding intensive care).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lille, Haut-de-France, 59000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nutritional assessment in COVID patients
Time frame: Up to 72 hours
The nutritional status of patients within the first 72 hours after hospital admission will be categorized according to the French Haute Authorité de Santé (France, 2019)
Time frame: Up to 72 hours
The supplemental oxygen requirement classified as follows:
Time frame: Up to 72 hours
The prognostic after hospitalization will be classified as follows:
Lille Catholic University
Other
Nutritional Assessment of French Hospitalized Patients Infected With COVID-19
Acronym: DenutCOVID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05870839
COVID-19, Coronaviridae Infections
Decatur, Georgia, United States
View Trial DetailsNCT05938075
COVID-19, Coronaviridae Infections
Johannesburg, Gauteng, South Africa
View Trial DetailsNCT04583319
COVID-19, Coronaviridae Infections
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04397588
ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2, Acute Refractory Heart Failure Related to SARS-CoV 2
Angers, France
View Trial Details